source
- Supreme Court to Hear Arguments on “Skinny Labeling” Case Impacting Generic Drug AccessThe U.S. Supreme Court scheduled oral arguments for Wednesday on a case concerning “skinny labeling,” a practice used by generic drug makers. Skinny labeling involves seeking approval to market a…
- Coultreon secures $125M Series A to advance oral immune drug into Phase 2 trialsCoultreon Biopharma announced a $125 million Series A financing round to fund development of an oral drug it licensed from Galapagos. The round was led by Sofinnova Investments and included nine i…